Press release from Companies
Publicerat: 2024-02-08 17:20:34
CHOSA Oncology announced today, 8th February 2024, the decision to postpone the release of its interim report for the fourth quarter of 2024. The previously communicated publication date of Friday, February 9, 2024, will be rescheduled to Thursday, February 29, 2024.
The company's performance throughout the fourth quarter has been in alignment with expectations and remains in accordance with the established financial plan. Operations have been executed in line with projections, and current funding is secured through the fourth quarter of 2024. The delay in publishing the quarterly report is attributed solely to unforeseen administrative circumstances that falls outside the Company's control. This disclosure contains information that Chosa Oncology AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 08-02-2024 17:20 CET. For additional information contact:
Peter Buhl Jensen, CEO
Peter@chosa.bio
+ 45 2160 8922
